European Heart Journal. Acute Cardiovascular Care
-
Publication Venue For
- Use of hospital resources in the care of patients with intermediate risk pulmonary embolism.. 2048872620921601. 2020
- Use of hospital resources in the care of patients with intermediate risk pulmonary embolism. 2020
- Incidence, predictors and prognosis of respiratory support in non-ST segment elevation myocardial infarction.. 2048872620919947. 2020
- Incidence, predictors and prognosis of respiratory support in non-ST segment elevation myocardial infarction. 2020
- Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology.. 9:183-197. 2020
- Copeptin to rule out myocardial infarction in Blacks versus Caucasians.. 8:395-403. 2019
- Relationship between community hospital versus pre-hospital location of randomisation and clinical outcomes in ST-elevation myocardial infarction patients: insights from the Stream study.. 7:504-513. 2018
- In reply to: "Intra-aortic balloon pump protects against hydrostatic pulmonary oedema during peripheral venoarterial-extracorporeal membrane oxygenation".. 2048872618779772. 2018
- Reperfusion ventricular arrhythmia bursts identify larger infarct size in spite of optimal epicardial and microvascular reperfusion using cardiac magnetic resonance imaging.. 7:246-256. 2018
- The impact of a failing right heart in patients supported by intra-aortic balloon counterpulsation.. 6:709-718. 2017
- Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial biomarker substudy.. 6:500-510. 2017
- Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial.. 6:155-163. 2017
- Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.. 5:231-242. 2016
- In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study.. 4:499-508. 2015
- Implications of ventricular arrhythmia "bursts" with normal epicardial flow, myocardial blush, and ST-segment recovery in anterior ST-elevation myocardial infarction reperfusion: a biosignature of direct myocellular injury "downstream of downstream".. 4:51-59. 2015
- Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial.. 3:246-256. 2014
- Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients.. 3:37-45. 2014
- Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS.. 2:246-255. 2013
- Management and outcomes of patients presenting with STEMI by use of chronic oral anticoagulation: results from the GRACE registry.. 2:280-291. 2013
- Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience. 2018
- Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS Trial. 2016